English Polski
Vol 18, No 2 (2023)
Review paper
Published online: 2022-10-26

open access

Page views 483
Article views/downloads 144
Get Citation

Connect on Social Media

Connect on Social Media

Catheter ablation of the cavo-tricuspid isthmus as a bridging therapy for symptomatic atrial fibrillation?

Tomasz Wcisło1, Michał Plewka1
DOI: 10.5603/FC.a2022.0059
Folia Cardiologica 2023;18(2):71-74.

Abstract

Atrial fibrillation and atrial flutter are the most common supraventricular arrhythmias. These arrhythmias often coexist, approximately one third of patients with atrial fibrillation presenting episodes of atrial flutter. Many physicians have difficulty making a correct diagnosis based on the electrocardiogram. However, it is fundamental for the choice of management strategy. Each arrhythmia has a different background, different sensitivity to pharmacological treatment and different approach to non-pharmacological treatment.

Article available in PDF format

View PDF Download PDF file

References

  1. Hindricks G, Potpara T, Dagres N, et al. et al.. ESC Scientific Document Group: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio Thoracic Surgery (EACTS). Eur Heart J. 2020; 42(5): 373–498.
  2. Neumann T, Vogt J, Schumacher B, et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol. 2008; 52(4): 273–278.
  3. Defaye P, Kane A, Chaib A, et al. Efficacy and safety of pulmonary veins isolation by cryoablation for the treatment of paroxysmal and persistent atrial fibrillation. Europace. 2011; 13(6): 789–795.
  4. Van Belle Y, Janse P, Rivero-Ayerza MJ, et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur Heart J. 2007; 28(18): 2231–2237.
  5. Verma A, Sanders P, Macle L, et al. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale. Am Heart J. 2012; 164(1): 1–6.e6.
  6. Adamowicz J, Szponder M, Sokołowska M, et al. Cavotricuspid isthmus ablation among patients with persistent atrial fi brillation as a bridging therapy to maintain sinus rhythm — a pilot study. Folia Cardiologica. 2017; 12(3): 239–244.
  7. Bianco I, Silva G, Forno A, et al. Risco de fibrilação atrial após ablação de flutter dependente de istmo cavo-tricuspídeo: vale a pena fazer a ablação da FA simultaneamente? Arq Bras Cardiol. 2020; 114(5): 775–782.
  8. Romanov A, Pokushalov E, Bayramova S, et al. Prophylactic pulmonary vein isolation during isthmus ablation for atrial flutter: Three-year outcomes of the PREVENT AF I study. J Cardiovasc Electrophysiol. 2018; 29(6): 872–878.